Adage Capital Partners Ups Investment in Amylin Pharmaceuticals (AMLN)
Posted on July 30th, 2012 by whalewisdom
Adage Capital Partners, a Boston hedge fund founded by Robert Atchinson, filed a new 13G disclosing ownership of 8,461,868 shares of AMLN as of July 20th. This gives Adage a 5.2% stake in the company and is an increase of 8,450,000 shares over what they reported on their March 31st 13F.
From Yahoo! Finance, Amylin Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drug candidates for the treatment of diabetes, obesity, and other diseases.
| Reported via | Date | Name | Ticker | Shares | % of Portfolio |
|---|---|---|---|---|---|
| 13F | 2004-12-31 | Amylin Pharmaceuticals, Inc. | AMLN | 150,000 | 0.03 |
| 13F | 2006-03-31 | Amylin Pharmaceuticals, Inc. | AMLN | 150,000 | 0.06 |
| 13F | 2007-12-31 | Amylin Pharmaceuticals, Inc. | AMLN | 400,000 | 0.08 |
| 13F | 2008-12-31 | Amylin Pharmaceuticals, Inc. | AMLN | 300,000 | 0.03 |
| 13F | 2010-03-31 | Amylin Pharmaceuticals, Inc. | AMLN | 500,000 | 0.05 |
| 13F | 2010-06-30 | Amylin Pharmaceuticals, Inc. | AMLN | 1,400,000 | 0.12 |
| 13F | 2010-09-30 | Amylin Pharmaceuticals, Inc. | AMLN | 850,000 | 0.08 |
| 13F | 2012-03-31 | Amylin Pharmaceuticals, Inc. | AMLN | 11,868 | 0.00 |
| SC 13G | 2012-07-20 | Amylin Pharmaceuticals, Inc. | AMLN | 8,461,868 | N/A |